Overview
Sen Matayoshi practices practicing medicine in Yonashiro-nishihara, Japan.
His clinical expertise encompasses Human Papillomavirus Infection and Head and Neck Squamous Cell Carcinoma (HNSCC).
He is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sen Matayoshi
Is Sen Matayoshi a top-rated expert for Human Papillomavirus Infection?
MediFind is an objective health platform that identifies experts based on real-world data. Sen Matayoshi is classified as an Experienced expert for Human Papillomavirus Infection, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sen Matayoshi participate in research or clinical trials?
Yes. Sen Matayoshi has published 14 articles and abstracts on conditions like Human Papillomavirus Infection. You can view a list of Sen Matayoshi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Head and Neck Squamous Cell Carcinoma (HNSCC)Mr. Matayoshi isExperienced. Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
- Human Papillomavirus InfectionMr. Matayoshi isExperienced. Learn about Human Papillomavirus Infection.